
Does the Wegovy pill cause thyroid cancer?
A boxed warning built on rodent studies, two conditions that rule the pill out, and four signs the label asks you to report.
Oolite Learn
Every question we could find about the GLP-1 pill, answered from the prescribing information. Updated as the labels change.

A boxed warning built on rodent studies, two conditions that rule the pill out, and four signs the label asks you to report.

Most reactions in the trials were on the skin, a few came within a day of the shot. What the label counts, and the signs that change everything.

Fridge first, 28 days out for the single dose pen, 56 days for the FlexTouch, and never the freezer.

One tablet a day is the rule. If two went down, the label names the call to make, and why it may take a while to settle.

A common side effect with a number, a link to antibodies, and the signs that make it something else.

Pain that stays, sometimes reaching the back. What the label counted, and what it asks you to do.

Studied together, no meaningful change in metformin levels, and one timing rule to keep: the tablet goes first.

The 4 day window, the 3 day gap, and why the two rules fit together on a calendar week.

The label's answer is not a pause but a sentence to say out loud: tell every provider before the procedure.

No best site in the label, the same exposure from all three, and one rule that matters: not the same spot twice.

Four doses per pen, six in the starting one, and the 56 day limit that applies even when some is left.

Same molecule, same-looking tablets, two labels. What is shared, what differs, and why they are never taken together.

One point three percent against zero point four. What the label measured, who it was more frequent in, and the fluid link.

Thirst is not on the list. Dehydration is, and the label explains why it matters for the kidneys.

Two percent overall, four percent with a blood pressure medicine. What the label measured, and what to tell your prescriber.

The 48 hour rule, worked out on a calendar week, and why two missed weeks in a row means a call before the next shot.

The label never names coffee. The shot has no food or drink rule, and the water only morning belongs to the tablets.

The label tested omeprazole and reflux disease with the tablet. What it found, and the 30 minutes that still apply.

One to four beats at rest on average, a bigger jump in one person in four. What the label measured on the weekly shot, and what it asks you to report.

The day after the last 25 mg tablet, 2.4 mg a week. The label's three cases, and the strengths it says nothing about.

Water only, up to 4 ounces, then 30 minutes. Coffee is a beverage like any other, and it waits.

One tablet a day is the rule. What the label says about too much, and the number it gives.

Twenty milligrams of simvastatin at most, the only statin with a limit on the label. What it measured for atorvastatin and rosuvastatin, and why spacing them out did not help.

Skip it, tomorrow as usual, never two. The label's rule for the tablet that replaced Rybelsus, and why one missed morning is not a restart.

Tested in the label's own study, no clinically significant change. Why Foundayo has a backup rule and the Wegovy pill does not, and the 30 minutes that still apply.

Comparable on average, wider from one person to the next. The one pair the label matches, and the doses it leaves without an equivalent.

A half-life of 29 to 49 hours, a week to build, about a week to clear. The label's numbers, drawn.

The approval, the pharmacies, the three million scripts, the two other tablets. The first year's dates, sourced.

The Medication Guide's own list: pancreatitis, severe stomach problems, dehydration, low blood sugar, allergy, vision, gallbladder, thyroid. Word for word.

The Medication Guide's own list: pancreatitis, gallbladder, dehydration, thyroid, allergy, low blood sugar. Word for word, nothing added.

The tablet label is silent, the injection label is not, and the modelled level after three weeks off is about an eighth. What to bring to the prescriber.

Five to seven weeks for the drug to leave, says the label. A year, in the injection trials, for two thirds of the change to return.

One has a morning ritual, the other has none. The rules, the half-lives and the steps, side by side, from the two labels.

The days on the step, the stomach by week, the missed mornings, the other tablets. What the label's decisions are made of.

Seven percent of women, under one percent of men, and the label's own sentence: it goes with the weight change, not the molecule.

Same list, same rates, says the label, with one effect the tablet has more of and one number it has more variation in.

What the label says the first month is, and is not. The strength, the climb, the stomach, and the ritual to learn.

Why the third week feels like a fade, what the label says a step is for, and the one number that explains the timing.

Two months before trying, says the label, and a different rule for breastfeeding on the tablet than on the injection.

Lower and more variable concentrations, says the label, and a reason to consider the injection. Plus the low blood sugar numbers.

Thirty days after the start and after every step up: the label's own rule for the birth control pill on Foundayo.

Stop when a pregnancy is recognized, not recommended while nursing, and a contraception rule most people have not read.

The routine that gives the coffee back. What the label asks for, what it says about the fast, and the two things that go wrong.

Two and a half percent versus one, the tablet's own figure. The four signs the Medication Guide asks you to call about.

At least 30, says the label. What 60 and 120 minutes measured, and why the label stopped at 30.

One to four beats on average, a bigger jump in one person in four. What the label measured and what it asks you to report.

Nine milligrams at most with a strong inhibitor, avoid strong inducers, watch the pill. The label's interaction rules in plain words.

7 becomes 4, 14 becomes 9, the day after the last old tablet, and never during the first month. The label's switching table.

From the 0.5 mg pen to the tablet: one week's wait, then 4 or 9 mg. The label's one switching rule for this direction.

One week after the last injection, 25 mg the next morning. The label's two rules, and the sentence about variability.

The label says once daily and nothing else. What an alternating schedule does to the level, and who gets to write one.

Three percent versus one on the label, and the sentence from the other pill's label that explains where it comes from.

Swallow whole, says the label. Why a tablet that already delivers 1 to 2 percent is not one to improvise with.

One sip with the tablet, then nothing until the timer. Why the label counts water as a beverage after the pill.

About a third of the level in one day, back within days. What the label says to do: take it as soon as possible.

Four to five beats a minute on average, 3 percent with a reported effect. What the label measured and what it asks you to report.

A slower stomach, says the label, and the three effects that follow: constipation, reflux, indigestion, with their rates.

About 9 percent, and the gap halves each week. What one skipped day does in a model built on the label's half-life, and what the label says about choosing to skip.

Two percent with type 2 diabetes, seven with a sulfonylurea, under one without diabetes. The label's numbers and its list of signs.

The label's table, strength by strength: nausea, constipation, diarrhea, vomiting, and the sentence about escalation.

Eleven percent versus five, says the label. The effect people are least prepared for, and what the label does and does not say about it.

The most common side effect, the numbers the label reports, and the two things it says to do about it.

No morning window, no water rule, no waiting. What the label does ask for, and why a fixed time helps with this molecule.

The gym does not change the label. The tablet, the sip, the 30 minutes, then the water bottle.

The label says morning and empty stomach, not seven o'clock. What the short-fast data says, and what to ask your prescriber.

Time zones, hotel breakfasts, the bottle in the suitcase. What the label asks for, and the one thing it never mentions.

The label wants the tablet in its bottle until the morning it is taken. Here is why, and what people use instead.

Room temperature, and nothing about light any more: what the July 2026 label changed, and the range that is safe on a hot day.

What the label says the first days are: 0.8 mg, any time, settled in a week, stomach effects higher during the escalation.

Three fixed steps, then three the prescriber chooses. At least 30 days each, 17.2 mg at most.

Thirty days a step, why the label escalates, and the two exits it writes down.

Same tablet, a schedule that stops at 4 mg. What the plan is, what the label says a step is for.

The pill first, 30 minutes, then the rest. And the 33 percent the label reports for levothyroxine.

Fibre, collagen, magnesium, the multivitamin: all of it waits 30 minutes, and the label's reason why.

With or without food, says the label, and here is the study behind those four words.

Take it as soon as you remember, never double up, and a seven day rule the Wegovy pill does not have.

A one week half-life, five to seven weeks to clear, four to five weeks to build. The label's numbers, drawn.

A sevenfold spread in the label's own numbers. Why the tablet varies more than the injection, and what it means for comparing notes.

Thirty days at 1.5, thirty at 4, then 4 or 9. The label's schedule for the tablet that replaced Rybelsus.

Same tablet, new name, half the dose numbers. The mapping, step by step.

Not a second tablet, not a wasted week: what the label and the food study say about the one morning that went wrong.

Skip it, take the next one tomorrow. The label's sentence, and what one day does to the level.

A third of a glass, two and a half shot glasses, 120 millilitres. Where the ceiling comes from and how people measure it.

Why the label says up to 4 ounces, and what a bigger glass did in the manufacturer's tests.

Water only, 4 ounces, 30 minutes. What the label says, and what the morning looks like in practice.

One to two percent, says the label, against 89 for the injection. The number behind every morning rule.
Tool
The pill level chart
How the Wegovy pill, Ozempic tablets or Foundayo build up day by day, what a missed morning costs, how long the pill lingers. From the label's half-life, no sign-up.
By treatment
Oral semaglutide · Novo Nordisk
The Wegovy pill, from the label
47 answers
Orforglipron · Eli Lilly
Foundayo, from the label
20 answers
Oral semaglutide · Novo Nordisk
Ozempic tablets, from the label
8 answers
Semaglutide, once weekly · Novo Nordisk
The Wegovy shot, from the label
7 answers
Semaglutide, once weekly · Novo Nordisk
The Ozempic shot, from the label
1 answer
Tirzepatide, once weekly · Eli Lilly
The Zepbound shot, from the label
3 answers
Oolite
The GLP-1 tracker for the pill and the shot.
The 30 minute timer, your shot day, the level chart and the dose reminder, on iPhone, with Apple Watch to log. Free to download, then a 14-day free trial.